WallStreetZenWallStreetZen

NASDAQ: CRSP
Crispr Therapeutics Ag Stock Ownership - Who owns Crispr Therapeutics Ag?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Crispr Therapeutics Ag insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Samarth KulkarniChief Executive Officer2025-10-1750,895$67.91
$3.46MSell
Samarth KulkarniChief Executive Officer2025-10-144,242$66.60
$282.52kSell
James R. KasingerGeneral Counsel and Secretary2025-10-141,076$66.60
$71.66kSell
Samarth KulkarniChief Executive Officer2025-08-1813,081$58.15
$760.66kSell
Douglas A. TrecoDirector2025-08-0620,000$57.03
$1.14MBuy
Simeon GeorgeDirector2025-07-166,510$52.03
$338.72kBuy
Simeon GeorgeDirector2025-07-16960,983$52.03
$50.00MBuy
Simeon GeorgeDirector2025-07-1622,319$52.03
$1.16MBuy
Naimish PatelChief Medical Officer2025-05-293,932$35.94
$141.32kSell
Raju PrasadChief Financial Officer2025-03-212,197$41.23
$90.58kSell

1 of 4

CRSP insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CRSP insiders and whales buy or sell their stock.

CRSP Shareholders

What type of owners hold Crispr Therapeutics Ag stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ark Investment Management LLC11.20%10,182,590$622.16MInstitution
Celgene Corp9.41%8,557,514$522.86MInsider
Blackrock Inc6.67%6,066,358$370.65MInstitution
Capital International Investors6.15%5,593,747$341.78MInstitution
Vertex Pharmaceuticals Europe Ltd5.92%5,380,940$328.78MInsider
Simeon George5.78%5,259,390$321.35MInsider
Bayer Global Investments Bv5.61%5,105,330$311.94MInsider
T Rowe Price Investment Management Inc4.05%3,683,026$225.03MInstitution
State Street Corp3.60%3,270,596$199.83MInstitution
Glaxosmithkline PLC3.54%3,220,627$196.78MInsider

1 of 3

CRSP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CRSP67.76%32.24%Net BuyingNet Selling
ARWR76.53%9.95%Net SellingNet Selling
PCVX88.06%11.94%Net SellingNet Selling
KRYS78.75%21.25%Net Selling
LEGN22.93%0.00%
View Top Biotech Stocks

Crispr Therapeutics Ag Stock Ownership FAQ

Who owns Crispr Therapeutics Ag?

Crispr Therapeutics Ag (NASDAQ: CRSP) is owned by 79.54% institutional shareholders, 37.84% Crispr Therapeutics Ag insiders, and 0.00% retail investors. Celgene Corp is the largest individual Crispr Therapeutics Ag shareholder, owning 8.56M shares representing 9.41% of the company. Celgene Corp's Crispr Therapeutics Ag shares are currently valued at $547.60M.

If you're new to stock investing, here's how to buy Crispr Therapeutics Ag stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.